Communicable Disease Investigation Reference Manual

Table of Contents

1.0  Introduction

(Revised 8/13)

2.0  Map - Districts for Statewide Disease Investigation/Terrorism Response/TB Control

(Updated 7/19)

3.0  Communicable Disease Surveillance

(Updated 12/14)

4.0  Diseases or Conditions

    Anaplasmosis

(Updated 10/24)

    Animal Bites / Injuries

(7/03)

    Anthrax

(Revised 2/11)

    Arboviral Diseases, Neuroinvasive and Non-Neuroinvasive

(Revised 4/15)

        California Serogroup Viruses, including La Crosse Virus

        Chikungunya Virus

        Eastern Equine Encephalitis Virus

        Powassan Virus

        St. Louis Encephalitis Virus

        Venezuelan Equine Encephalitis Virus

        West Nile

        Western Equine Encephalitis

    Babesiosis

(Revised 7/25)

    Botulism

(Revised 12/13)

    Brucellosis

(Revised 10/13)

    Campylobacteriosis

(Updated 10/23)

    Cholera

(Updated 4/12)

    Coccidioidomycosis

(Revised 1/12)

    Creutzfeldt-Jakob Disease

(Revised 5/16)

    Cryptosporidiosis

(Revised 8/11)

    Cyclosporiasis

(Revised 10/11)

    Dengue

(Revised 7/25)

    Diphtheria

(Updated 3/12)

    Escherichia coli O157:H7/Other Hemorrhagic E. coli

(Revised 6/11)

    Ehrlichiosis

(Updated 10/24)

    Giardiasis

(Revised 2/14)

    Haemophilus influenzae, Invasive

(Revised 1/15)

    Hansen's Disease (Leprosy)

(Revised 4/12)

    Hantavirus Infections

(Revised 6/15)

    Hemolytic Uremic Syndrome (HUS), post-diarrheal

(Updated 6/24)

    Hemorrhagic Fevers (Viral)

(Updated 11/15)

         Arenaviridae: South American Hemorrhagic Viral Fevers (New World Arenaviruses)

         Arenaviridae: Lassa Fever (Old World Arenavirus)

         Bunyaviridae: Crimean-Congo Hemorrhagic Fever

         Filoviridae: Ebola Hemorrhagic Fever

         Filoviridae: Marburg Hemorrhagic Fever

    Hepatitis A

(Updated 6/23)

    Influenza

(Updated 6/17)

    Latent Tuberculosis Infection

(Revised 3/14)

    Legionellosis

(Revised 2/24)

    Leptospirosis

(Updated 11/15)

    Listeriosis

(Updated 1/14)

    Lyme Disease

(Revised 6/25)

    Malaria

(Revised 3/14)

    Measles

(Updated 3/25)

    Meningococcal Disease

(Updated 7/23)

    Methicillin–resistant Staphylococcus aureus (MRSA)

(5/11)

    Mumps

(Revised 8/13)

    Nontuberculous Mycobacterium (NTM) / MOTT

(Revised 1/15)

    Outbreak Investigation

(Updated 6/24)

    Paragonimiasis

(2/11)

    Perinatal Hepatitis B Case Management Form - PHB 29

    Pertussis

(Updated 8/23)

    Plague

(Revised 9/12)

    Polio

(Updated 5/12)

    Psittacosis

(Revised 1/16)

    Q fever

(Revised 5/15)

    Rabies

          Rabies, animal

(Revised 1/14)

          Rabies, human

(Revised 1/14)

    Ricin

(Updated 2/13)

    Rocky Mountain Spotted Fever/Spotted Fever Rickettsioses

(Updated 10/24)

    Rubella

(Revised 11/13)

    Salmonellosis, Nontyphoidal (NTS)

(Revised 6/17)

    Shiga toxin-producing E. coli (STEC) and
    Shiga toxin positive, unknown organism

(Revised 6/11)

    Shigellosis

(Updated 9/23)

    Streptococcus pneumoniae, Invasive Pneumococcal Disease (IPD)

(New 6/17)

    Streptococcal Toxic Shock Syndrome

(Revised 2/16)

    T-2 Mycotoxicosis

Revised (5/16)

    Tetanus

(Revised 11/13)

    Toxic Shock Syndrome, Non-Streptococcal

(Revised 5/16)

    Trichinellosis

(Revised 4/15)

    Tuberculosis Disease

(Revised 3/12)

    Tularemia

(Revised 7/25)

    Typhoid & Paratyphoid Fever

(Revised 7/15)

    Vaccinia, Adverse Reactions

(Revised 4/05)

    Vancomycin-Intermediate Staphylococcus aureus (VISA) and     Vancomycin-Resistant Staphylococcus aureus (VRSA)

(5/11)

    Varicella (Chickenpox)

(Revised 5/11)

    Vibriosis (non-cholera Vibrio species infections)

(11/12)

    Yellow Fever

(Revised 7/25)

    Yersiniosis

(Revised 3/12)

Key

New

Recently added manual section.

Reviewed

Section content is current.

Revised

Section content:  may include reporting guidelines, forms, and intervention recommendations.

Updated

Web links, agency names and phone numbers.